101249-96-1 Usage
Description
,R)>-phenylmethyl 2-<<<1-<(carboxymethoxy)methyl>-3-methylbutyl>amino>carbonyl>-1-pyrrolidinecarboxylate is a complex organic compound with a pyrrolidinecarboxylate core. It features a phenylmethyl group attached to the first carbon of the pyrrolidine ring and a 2-<1-(carboxymethoxy)methyl>-3-methylbutylamino substituent at the second carbon. The molecule also includes a carbonyl group and an additional carboxylate group, which may contribute to its potential bioactivity. The specific stereochemistry of the substituents at the pyrrolidine ring is crucial for its properties and potential applications.
Uses
Used in Pharmaceutical Industry:
,R)>-phenylmethyl 2-<<<1-<(carboxymethoxy)methyl>-3-methylbutyl>amino>carbonyl>-1-pyrrolidinecarboxylate is used as a potential pharmaceutical compound for its unique chemical structure and stereochemistry. The presence of the phenylmethyl group, carbonyl group, and carboxylate group may allow for interactions with biological targets, making it a candidate for drug development.
Used in Agrochemical Industry:
In the agrochemical industry, ,R)>-phenylmethyl 2-<<<1-<(carboxymethoxy)methyl>-3-methylbutyl>amino>carbonyl>-1-pyrrolidinecarboxylate may be utilized as a starting material or intermediate in the synthesis of bioactive molecules with potential applications in pest control, crop protection, or as additives to enhance plant growth and health.
Check Digit Verification of cas no
The CAS Registry Mumber 101249-96-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,2,4 and 9 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 101249-96:
(8*1)+(7*0)+(6*1)+(5*2)+(4*4)+(3*9)+(2*9)+(1*6)=91
91 % 10 = 1
So 101249-96-1 is a valid CAS Registry Number.
101249-96-1Relevant articles and documents
Modified Di- and Tripeptides of the C-Terminal Portion of Oxytocin and Vasopressin as Possible Cognition Activation Agents
Nicolaides, E. D.,Tinney, F. J.,Kaltenbronn, J. S.,Repine, J. T.,DeJohn, D. A.,et al.
, p. 959 - 971 (2007/10/02)
A number of peptides and modified peptides were synthesized and studied for their ability to reverse electroconvulsive shock-induced amnesia in rodents.A few of these peptides were selected for secondary evaluation in tests of short-term memory in rats and aged rhesus monkeys.A number of the peptides and modified peptides were active in the amnesia reversal test.In selected secondary tests, however, the chosen compounds failed to show significant activity in enhancing memory.New methods for preparing methyleneamino and methyleneoxy isosters of peptides are reportrd.Other modified peptides also included methylenethio, methylenesulfonyl, and ethylene isosteres in place of the normal peptide amide bond.
